Attending community-based lung cancer screening influences smoking behaviour in deprived populations.


Journal

Lung cancer (Amsterdam, Netherlands)
ISSN: 1872-8332
Titre abrégé: Lung Cancer
Pays: Ireland
ID NLM: 8800805

Informations de publication

Date de publication:
01 2020
Historique:
received: 19 09 2019
accepted: 24 10 2019
pubmed: 15 11 2019
medline: 5 2 2021
entrez: 15 11 2019
Statut: ppublish

Résumé

The impact of lung cancer screening on smoking is unclear, especially in deprived populations who are underrepresented in screening trials. The aim of this observational cohort study was to investigate whether a community-based lung cancer screening programme influenced smoking behaviour and smoking attitude in socio-economically deprived populations. Ever-smokers, age 55-74, registered at participating General Practices were invited to a community-based Lung Health Check (LHC). This included an assessment of respiratory symptoms, lung cancer risk (PLCO 919 participants (51% women) were included in the analysis (77% of attendees); median deprivation rank in the lowest decile for England. At baseline 50.3% were current smokers. One-year quit rate was 10.2%, quitting was associated with increased baseline symptoms ( Our data suggest a community-based lung cancer screening programme in deprived areas positively impacts smoking behaviour, with no evidence of a 'licence to smoke' in those screened.

Identifiants

pubmed: 31726252
pii: S0169-5002(19)30706-8
doi: 10.1016/j.lungcan.2019.10.025
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-46

Subventions

Organisme : Cancer Research UK
ID : C147/A18083
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C147/A25254
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Haval Balata (H)

Manchester Thoracic Oncology Centre, North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK. Electronic address: haval.balata@mft.nhs.uk.

Liam Traverse-Healy (L)

University of Manchester Medical School, Manchester, UK.

Sean Blandin-Knight (S)

Manchester Thoracic Oncology Centre, North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Christopher Armitage (C)

Manchester Centre for Health Psychology, Division of Psychology and Mental Health, School of Health Sciences, University of Manchester, Manchester, UK.

Philip Barber (P)

Manchester Thoracic Oncology Centre, North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Denis Colligan (D)

Manchester Health and Care Commissioning, Manchester, UK.

Peter Elton (P)

Greater Manchester Health & Social Care Partnership, Manchester, UK.

Marie Kirwan (M)

Thoracic Oncology Research Hub (TORCH), Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Judith Lyons (J)

Manchester Thoracic Oncology Centre, North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Lorna McWilliams (L)

Christie Patient Centred Research, Division of Nursing, Midwifery & Social Work, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.

Juliette Novasio (J)

Thoracic Oncology Research Hub (TORCH), Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Anna Sharman (A)

Department of Radiology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Kathryn Slevin (K)

Thoracic Oncology Research Hub (TORCH), Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Sarah Taylor (S)

Manchester Health and Care Commissioning, Manchester, UK.

Janet Tonge (J)

Manchester Health and Care Commissioning, Manchester, UK.

Sara Waplington (S)

Thoracic Oncology Research Hub (TORCH), Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Janelle Yorke (J)

Christie Patient Centred Research, Division of Nursing, Midwifery & Social Work, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.

Matthew Evison (M)

Manchester Thoracic Oncology Centre, North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Richard Booton (R)

Manchester Thoracic Oncology Centre, North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK.

Philip A J Crosbie (PAJ)

Manchester Thoracic Oncology Centre, North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH